A reduction in IL-22 levels impacts ovarian shape and follicle development whereas GDCA promotes the PCOS phenotype by binding to ILC3 (innate lymphoid cell type 3) and GATA3 (GATA binding protein 3) and raising IL-22 production [24]. This evidence concerns the gene IL22 and polycystic ovary syndrome.